cannabis product
Canna Law Blog

Why Cannabis Product Review is So Important

Over the last five years, I’ve done countless compliance reviews for cannabis product and CBD product labels, packaging materials, and products themselves. In all cases – not most, all – cannabis product labels needed at least one change. Product type, shape, and ingredients often needed work. And even packaging material has had plenty of issues.

cbd
Canna Law Blog

Congress Wants to Hear from You on CBD by August 18th

Today’s public service announcement is that Congress wants to hear from you on a regulatory fix for cannabidiol (CBD) and other hemp-derived cannabinoid products. The request came down via the Energy and Commerce Committee on July 27, when it published a Request for Information (RFI) to “interested parties” on the topic. The deadline for RFI

China lawyers on social media
China Law Blog

China and International Social Media Postings: Please Join Us!

A lot is happening these days in and with China and around the world. Obviously. Much of our law firm’s legal work has lately been focused on helping clients deal with a China that is internally fracturing and slowly but surely decoupling from the rest of the world. Today I just saw that China’s exports

kratom
Canna Law Blog

Cannabinoid Folks, Pay Attention to Kratom

It seems as if there is a new cannabinoid product coming out every five minutes. Scratch that – it seems like there is a new cannabinoid coming out every five minutes. After CBD, it was CBG and CBN, then the deltas, and then, well, it’s hard to keep track. Today, every time I research these new

canna law blog
Canna Law Blog

U.S. Import and Export of Marijuana, Hemp and Paraphernalia: Webinar Recap

In case you missed our webinar this week, “U.S. Import and Export of Marijuana, Hemp and Paraphernalia”, the replay video is just above. And if you don’t have an hour to spare, below are highlights of what our cannabis and international trade lawyers had to say about the status and pitfalls of the international cannabis

hemp
Canna Law Blog

What Happened to Hemp?

Last week, a LinkedIn post by cannabis economist Beau Whitney caught my eye, because Beau said something pretty amazing. He said: “licensed acres in hemp are at pre-farm bill levels.” Could that be true? Before the 2018 Farm Bill, only a few states ran limited “research” pilot programs for hemp. I did my best to

cannabis advertising
Canna Law Blog

Be Very Skeptical of Cannabis Advertising

The level of straight-up false information in cannabis advertising online is staggering. It’s almost too hard to describe. As a cannabis attorney, I’m often stunned that companies push cannabis advertisements the way they do. Over the years, I’ve spoken to dozens (maybe hundreds) of cannabis business owners who thought X was completely legal because of

Top Five E-commerce mistakes
Post

Top 5 E-Commerce Mistakes, and How to Avoid Them

E-commerce businesses are easy targets for lawsuits. Unlike traditional brick-and-mortar businesses, everything e-commerce businesses do is online for billions of people to see with the click of a button. So, the massive uptick in e-commerce litigation in recent years should not surprise anybody. Despite these increased risks for e-commerce businesses, many make massive mistakes in

washington thc
Canna Law Blog

Washington Releases Rules Guidance on SB 5367 (Products Containing THC)

The Washington State Liquor and Cannabis Board (WSLCB) released a rules guide on July 14, “outlining regulations of products containing THC”. The guide is titled “Discontinued Sales of Products Containing THC by Businesses that Do Not Hold a Cannabis License” and it relates to recently enacted SB 5367, which we’ve been following closely. As we

delta 8
Canna Law Blog

FDA and FTC Target Delta-8 Products

On July 5, 2023, the FDA and FTC jointly announced six cease and desist letters to alleged delta-8 product makers. You can access the letters here. Unlike prior rounds of warning letters, these letters have a new focus: harm to children. For nearly five years, the FDA and FTC have taken the position that CBD